Cargando…

Remission and relapses of myasthenia gravis on long-term tacrolimus: a retrospective cross-sectional study of a Chinese cohort

OBJECTIVE: To identify the factors that predict the remission and relapses in myasthenia gravis (MG) patients improved by prednisone and tacrolimus treatment. METHODS: A retrospective, observational cohort analysis of MG patients who achieved remission after receiving prednisone and tacrolimus were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bi, Zhuajin, Cao, Yayun, Liu, Chenchen, Gui, Mengcui, Lin, Jing, Zhang, Qing, Li, Yue, Ji, Suqiong, Bu, Bitao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459458/ https://www.ncbi.nlm.nih.gov/pubmed/36093262 http://dx.doi.org/10.1177/20406223221122538

Ejemplares similares

Long-Term Improvement in a Chinese Cohort of Glucocorticoid-Resistant Childhood-Onset Myasthenia Gravis Patients Treated With Tacrolimus
por: Bi, Zhuajin, et al.
Publicado: (2022)

Dynamic nomogram for predicting generalized conversion in adult-onset ocular myasthenia gravis
por: Bi, Zhuajin, et al.
Publicado: (2022)

Guillain-Barré syndrome associated with myasthenia gravis: Three cases report and a literature review
por: Cao, Yayun, et al.
Publicado: (2019)

Childhood-Onset Myasthenia Gravis Patients Benefited from Thymectomy in a Long-Term Follow-up Observation
por: Zhang, Qing, et al.
Publicado: (2022)

Polymorphisms in drug metabolism genes predict the risk of refractory myasthenia gravis
por: Zhang, Qing, et al.
Publicado: (2022)

Clinical and immune-related factors associated with exacerbation in adults with well-controlled generalized myasthenia gravis
por: Bi, Zhuajin, et al.
Publicado: (2023)

Efficacy of tacrolimus as long-term immunotherapy for neuronal surface antibody-mediated autoimmune encephalitis
por: Liu, Chenchen, et al.
Publicado: (2022)

Upregulation of circ‐FBL promotes myogenic proliferation in myasthenia gravis by regulation of miR‐133/PAX7
por: Lai, Xiaoyin, et al.
Publicado: (2021)

Overlapping syndrome mimicking infectious meningoencephalitis in a patient with MOG and GFAP IgG
por: Ji, Suqiong, et al.
Publicado: (2021)

Increased expression of cell adhesion molecules in myofasciitis
por: Ma, Xue, et al.
Publicado: (2023)

Hypertrophic Pachymeningitis in Chinese Patients: Presentation, Radiological Findings, and Clinical Course
por: Bi, Zhuajin, et al.
Publicado: (2020)

Favorable Effects of Tacrolimus Monotherapy on Myasthenia Gravis Patients
por: Fan, Zhirong, et al.
Publicado: (2020)

Long-Term Safety and Efficacy of Tacrolimus in Myasthenia Gravis
por: Kim, Yool-hee, et al.
Publicado: (2019)

The accumulation of muscle RING finger-1 in regenerating myofibers: Implications for muscle repair in immune-mediated necrotizing myopathy
por: Yang, Meng-Ge, et al.
Publicado: (2022)

Tacrolimus Combined with Corticosteroids Improved the Outcome of CIDP Patients with Autoantibodies Against Paranodal Proteins
por: Yang, Meng-ge, et al.
Publicado: (2022)

Comparison between mono‐tacrolimus and mono‐glucocorticoid in the treatment of myasthenia gravis
por: Fan, Zhirong, et al.
Publicado: (2023)

Immunotherapy choice and maintenance for generalized myasthenia gravis in China
por: Zhang, Chao, et al.
Publicado: (2020)

Relapsed Myasthenia Gravis after Nivolumab Treatment
por: Mitsune, Ayumi, et al.
Publicado: (2018)

Efficacy and Safety of Tacrolimus Therapy for a Single Chinese Cohort With Very-Late-Onset Myasthenia Gravis
por: Zheng, Yiming, et al.
Publicado: (2022)

Efficacy and Safety of Tacrolimus in Myasthenia Gravis: A Systematic Review and Meta-analysis
por: Zhang, Zuojie, et al.
Publicado: (2017)

Tacrolimus as Single-Agent Immunotherapy and Minimal Manifestation Status in Nonthymoma Myasthenia Gravis
por: Duan, Weiwei, et al.
Publicado: (2021)

Tacrolimus in the treatment of myasthenia gravis in patients with an inadequate response to glucocorticoid therapy: randomized, double-blind, placebo-controlled study conducted in China
por: Zhou, Lei, et al.
Publicado: (2017)

Clinical Evaluation of the Efficacy and Safety of Co-Administration of Wuzhi Capsule and Tacrolimus in Adult Chinese Patients with Myasthenia Gravis
por: Peng, Yuyao, et al.
Publicado: (2021)

Remission of severe myasthenia gravis after autologous stem cell transplantation
por: Schlatter, Monica I., et al.
Publicado: (2023)

Evaluation of the Quantitative Myasthenia Gravis Score and Grip Strength in Chinese Patients With Myasthenia Gravis: An Observational Study
por: Li, Jinghao, et al.
Publicado: (2021)

Myasthenia gravis
por: Juel, Vern C, et al.
Publicado: (2007)

Myasthenia Gravis
por: Aarli, Johan A., et al.
Publicado: (2011)

Myasthenia Gravis
Publicado: (1905)

Myasthenia Gravis
por: Wilson, Andrew
Publicado: (1952)

Myasthenia Gravis
por: Bramwell, Edwin
Publicado: (1901)

Prospective study of stress, depression and personality in myasthenia gravis relapses
por: Bogdan, Anca, et al.
Publicado: (2020)

Pembrolizumab-induced Myasthenia Gravis Relapse after Immunosuppressive Therapy
por: Oshima, Yuki, et al.
Publicado: (2022)

Complete Remission of Generalized Myasthenia Gravis by Corticosteroid Treatment Alone without Thymectomy
por: Kataoka, Hiroshi, et al.
Publicado: (2011)

Remission of Severe Myasthenia Gravis After Massive-Dose Vitamin D Treatment
por: Cadegiani, Flávio Adsuara
Publicado: (2016)

Thymectomy for myasthenia gravis
por: Moorehead, R J, et al.
Publicado: (1985)

Thymectomy in Myasthenia Gravis
por: Dunlop, D. M.
Publicado: (1953)

Thymectomy in Myasthenia Gravis
por: Brown, K. Paterson
Publicado: (1953)

Thymectomy for Myasthenia Gravis
por: Keynes, Geoffrey
Publicado: (1949)

The epidemiology of myasthenia gravis
por: Bubuioc, Ana-Maria, et al.
Publicado: (2021)

Diagnosis of Myasthenia Gravis
por: Rousseff, Rossen T.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h59t3ahsa8815o2dede7o8hfjq